000 | 01147 a2200325 4500 | ||
---|---|---|---|
005 | 20250511202624.0 | ||
264 | 0 | _c19920313 | |
008 | 199203s 0 0 eng d | ||
022 | _a0041-1337 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAdams, M B | |
245 | 0 | 0 |
_aEnisoprost in renal transplantation. The Enisoprost Renal Transplant Study Group. _h[electronic resource] |
260 |
_bTransplantation _cFeb 1992 |
||
300 |
_a338-45 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAlprostadil _xadverse effects |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aAntilymphocyte Serum _xtherapeutic use |
650 | 0 | 4 |
_aCyclosporine _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGraft Rejection _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
650 | 0 | 4 |
_aKidney _xdrug effects |
650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
650 | 0 | 4 |
_aKidney Tubular Necrosis, Acute _xphysiopathology |
650 | 0 | 4 | _aMale |
773 | 0 |
_tTransplantation _gvol. 53 _gno. 2 _gp. 338-45 |
|
999 |
_c1745324 _d1745324 |